BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26485622)

  • 1. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium.
    Vieira AGS; Puthenpura V; Krailo M; Fallahazad N; Brougham MFH; Murray MJ; Frazier AL; Lopes LF; Pashankar F
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30426. PubMed ID: 37243320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
    Marina NM; Cushing B; Giller R; Cohen L; Lauer SJ; Ablin A; Weetman R; Cullen J; Rogers P; Vinocur C; Stolar C; Rescorla F; Hawkins E; Heifetz S; Rao PV; Krailo M; Castleberry RP
    J Clin Oncol; 1999 Jul; 17(7):2137-43. PubMed ID: 10561269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
    Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
    Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
    Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
    Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
    J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.
    Göbel U; Calaminus G; Schneider DT; Koch S; Teske C; Harms D
    Klin Padiatr; 2006; 218(6):309-14. PubMed ID: 17080332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature and immature teratoma: A report from the second Italian pediatric study.
    Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G
    Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
    Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
    [No Abstract]   [Full Text] [Related]  

  • 18. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII).
    Depani S; Stoneham S; Krailo M; Xia C; Nicholson J
    Eur J Cancer; 2019 Sep; 118():49-57. PubMed ID: 31306943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.